文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

解析多发性骨髓瘤的生物学特性:癌症干细胞、获得性细胞内变化以及与周围微环境的相互作用。

Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment.

作者信息

Caers Jo, Van Valckenborgh Els, Menu Eline, Van Camp Benjamin, Vanderkerken Karin

机构信息

Laboratory of Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium.

出版信息

Bull Cancer. 2008 Mar;95(3):301-13. doi: 10.1684/bdc.2008.0600.


DOI:10.1684/bdc.2008.0600
PMID:18390410
Abstract

Cancerogenesis is believed to be a multistep process composed of different alterations that drive the transformation of normal human cells into highly malignant derivatives. These changes include self-sufficiency in growth signals, insensitivity to growth-inhibitory signals, the evasion of programmed cell death, a limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis. Some evidence suggests that these cancer cells are derived from immature, proliferative precursors that feed the cancer cell compartment. Both, precursors and cancer cells, intensively interact with their surroundings, commonly described as their micro-environment. The processes above are also important in the biology of multiple myeloma, a malignant bone marrow disorder consisting of monoclonal plasma cells accumulation. In the current review we describe the biology of this disease, stressing the origin of myeloma cells, their acquired genetic changes and interactions with their bone marrow microenvironment.

摘要

癌症发生被认为是一个多步骤过程,由不同的改变组成,这些改变驱动正常人类细胞转变为高度恶性的衍生物。这些变化包括生长信号的自我充足、对生长抑制信号不敏感、逃避程序性细胞死亡、无限的复制潜能、持续的血管生成以及组织侵袭和转移。一些证据表明,这些癌细胞源自为癌细胞区室提供补充的未成熟增殖前体细胞。前体细胞和癌细胞都与它们的周围环境密切相互作用,通常将其周围环境描述为微环境。上述过程在多发性骨髓瘤(一种由单克隆浆细胞积聚组成的恶性骨髓疾病)的生物学中也很重要。在当前综述中,我们描述了这种疾病的生物学特性,重点强调骨髓瘤细胞的起源、其获得的基因变化以及与骨髓微环境的相互作用。

相似文献

[1]
Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment.

Bull Cancer. 2008-3

[2]
Ion channels and the hallmarks of cancer.

Trends Mol Med. 2010-2-16

[3]
MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype.

Endocr Relat Cancer. 2010-1-29

[4]
Transcription factors: their potential as targets for an individualized therapeutic approach to cancer.

Cancer Gene Ther. 2009-2

[5]
NF-kappaB in solid tumors.

Biochem Pharmacol. 2006-10-30

[6]
Angiogenesis in multiple myeloma.

Eur J Cancer. 2006-7

[7]
Homing mechanisms in the etiopathogenesis of multiple myeloma.

Stem Cells. 1995-8

[8]
Cancer stem cells and the cellular hierarchy in haematological malignancies.

Eur J Cancer. 2009-9

[9]
Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication.

Ann N Y Acad Sci. 2004-12

[10]
Cancer: determinants and progression.

Nepal Med Coll J. 2005-6

引用本文的文献

[1]
Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death.

Blood Adv. 2024-8-13

[2]
Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma.

Int J Mol Sci. 2021-8-21

[3]
Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism.

Sci Rep. 2019-1-31

[4]
Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease.

Haematologica. 2018-5-10

[5]
NF-Kβ Activation in U266 Cells on Mesenchymal Stem Cells.

Adv Pharm Bull. 2016-9

[6]
SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma.

Oncotarget. 2016-5-24

[7]
Serum 8-isoprostane levels and paraoxonase 1 activity in patients with stage I multiple myeloma.

Redox Rep. 2016-9

[8]
SGK3 (CISK) may induce tumor angiogenesis (Hypothesis).

Oncol Lett. 2015-7

[9]
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.

Blood. 2014-12-11

[10]
Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.

PLoS One. 2014-2-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索